Shenanigans in WHO South-East Asia as Politician’s Daughter Contests Regional Director Election 18/09/2023 Mukesh Kapila Election fever is sweeping through the World Health Organization (WHO) in three of its six regions – Eastern Mediterranean (EMRO), South-East Asia (SEARO), and Western Pacific (WPRO). It matters who becomes their regional directors because they have considerable decentralised authority to influence the health chances of billions. Its regions also make or break WHO globally. […] Continue reading -> UN Political Declaration on Universal Health Coverage: Ambitious Aspirations Against Litany of Failures 15/09/2023 Elaine Ruth Fletcher NEW YORK CITY – There has been little progress in expanding universal health service coverage (UHC) since the last UN High Level Meeting (HLM) meeting on the issue in 2019, and trends in financial protection are even worsening, with catastrophic out-of-pocket spending increasing when compared to 2015. The final draft of the political declaration for […] Continue reading -> Eastern Mediterranean Countries Deserve Better Health: Will the New WHO Regional Director Deliver That? 24/08/2023 Mukesh Kapila For most people, electing the regional director – or chief health officer – for the Eastern Mediterranean Region (EMRO) of the World Health Organization (WHO) will not set the pulse racing. Is this just another shuffling of chairs around the world’s bureaucratic table? Even among global health nerds, it will trigger just a faint tremor. […] Continue reading -> World Needs to Dramatically Scale Up Hepatitis Testing and Treatment 28/07/2023 Mandi Smallhorne Viral hepatitis could become a more lethal killer than malaria, tuberculosis and HIV combined by 2040, if current trends in undetected infection and treatment continue, warned the World Health Organisation (WHO) on Friday, World Hepatitis Day. In observance of the day, WHO launched a call, under the title “One life, one liver”, to scale up […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> EXCLUSIVE: UN Draft Declaration on Pandemics Is Aspirational Rather Than Action-Oriented 24/07/2023 Kerry Cullinan The final reading of the Political Declaration for the United Nations High-Level Meeting on Pandemic Prevention, Preparedness and Response (PPPR) is scheduled for Tuesday in New York – and while the revised text has a few more practical clauses than the bland zero-draft, it remains more aspirational than actionable. The draft Political Declaration, which has […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
UN Political Declaration on Universal Health Coverage: Ambitious Aspirations Against Litany of Failures 15/09/2023 Elaine Ruth Fletcher NEW YORK CITY – There has been little progress in expanding universal health service coverage (UHC) since the last UN High Level Meeting (HLM) meeting on the issue in 2019, and trends in financial protection are even worsening, with catastrophic out-of-pocket spending increasing when compared to 2015. The final draft of the political declaration for […] Continue reading -> Eastern Mediterranean Countries Deserve Better Health: Will the New WHO Regional Director Deliver That? 24/08/2023 Mukesh Kapila For most people, electing the regional director – or chief health officer – for the Eastern Mediterranean Region (EMRO) of the World Health Organization (WHO) will not set the pulse racing. Is this just another shuffling of chairs around the world’s bureaucratic table? Even among global health nerds, it will trigger just a faint tremor. […] Continue reading -> World Needs to Dramatically Scale Up Hepatitis Testing and Treatment 28/07/2023 Mandi Smallhorne Viral hepatitis could become a more lethal killer than malaria, tuberculosis and HIV combined by 2040, if current trends in undetected infection and treatment continue, warned the World Health Organisation (WHO) on Friday, World Hepatitis Day. In observance of the day, WHO launched a call, under the title “One life, one liver”, to scale up […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> EXCLUSIVE: UN Draft Declaration on Pandemics Is Aspirational Rather Than Action-Oriented 24/07/2023 Kerry Cullinan The final reading of the Political Declaration for the United Nations High-Level Meeting on Pandemic Prevention, Preparedness and Response (PPPR) is scheduled for Tuesday in New York – and while the revised text has a few more practical clauses than the bland zero-draft, it remains more aspirational than actionable. The draft Political Declaration, which has […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Eastern Mediterranean Countries Deserve Better Health: Will the New WHO Regional Director Deliver That? 24/08/2023 Mukesh Kapila For most people, electing the regional director – or chief health officer – for the Eastern Mediterranean Region (EMRO) of the World Health Organization (WHO) will not set the pulse racing. Is this just another shuffling of chairs around the world’s bureaucratic table? Even among global health nerds, it will trigger just a faint tremor. […] Continue reading -> World Needs to Dramatically Scale Up Hepatitis Testing and Treatment 28/07/2023 Mandi Smallhorne Viral hepatitis could become a more lethal killer than malaria, tuberculosis and HIV combined by 2040, if current trends in undetected infection and treatment continue, warned the World Health Organisation (WHO) on Friday, World Hepatitis Day. In observance of the day, WHO launched a call, under the title “One life, one liver”, to scale up […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> EXCLUSIVE: UN Draft Declaration on Pandemics Is Aspirational Rather Than Action-Oriented 24/07/2023 Kerry Cullinan The final reading of the Political Declaration for the United Nations High-Level Meeting on Pandemic Prevention, Preparedness and Response (PPPR) is scheduled for Tuesday in New York – and while the revised text has a few more practical clauses than the bland zero-draft, it remains more aspirational than actionable. The draft Political Declaration, which has […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Needs to Dramatically Scale Up Hepatitis Testing and Treatment 28/07/2023 Mandi Smallhorne Viral hepatitis could become a more lethal killer than malaria, tuberculosis and HIV combined by 2040, if current trends in undetected infection and treatment continue, warned the World Health Organisation (WHO) on Friday, World Hepatitis Day. In observance of the day, WHO launched a call, under the title “One life, one liver”, to scale up […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> EXCLUSIVE: UN Draft Declaration on Pandemics Is Aspirational Rather Than Action-Oriented 24/07/2023 Kerry Cullinan The final reading of the Political Declaration for the United Nations High-Level Meeting on Pandemic Prevention, Preparedness and Response (PPPR) is scheduled for Tuesday in New York – and while the revised text has a few more practical clauses than the bland zero-draft, it remains more aspirational than actionable. The draft Political Declaration, which has […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> EXCLUSIVE: UN Draft Declaration on Pandemics Is Aspirational Rather Than Action-Oriented 24/07/2023 Kerry Cullinan The final reading of the Political Declaration for the United Nations High-Level Meeting on Pandemic Prevention, Preparedness and Response (PPPR) is scheduled for Tuesday in New York – and while the revised text has a few more practical clauses than the bland zero-draft, it remains more aspirational than actionable. The draft Political Declaration, which has […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
EXCLUSIVE: UN Draft Declaration on Pandemics Is Aspirational Rather Than Action-Oriented 24/07/2023 Kerry Cullinan The final reading of the Political Declaration for the United Nations High-Level Meeting on Pandemic Prevention, Preparedness and Response (PPPR) is scheduled for Tuesday in New York – and while the revised text has a few more practical clauses than the bland zero-draft, it remains more aspirational than actionable. The draft Political Declaration, which has […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy